Funded Tech Companies
Intellia Therapeutics
Intellia Therapeutics is a biopharmaceutical company, located in Cambridge. Financial backing was provided by Fidelity Management & Research Company, OrbiMed and Foresite Capital.
Company Overview
Company Name
Intellia Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
40 Erie St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Intellia (NASDAQ: NTLA) is a leading gene editing company, focused on the development of proprietary, potentially curative therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/6/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Leonard
Chief Financial Officer
Glenn Goddard
Vice President
Eliana Clark
VP - Bus. Development
Christine Foster
VP - General Counsel
Nishla Keiser
VP - General Counsel
Jose Rivera
Company Investors
- Fidelity Management & Research Company
- OrbiMed (Carl Gordon)
- Foresite Capital
- EcoR1 Capital Management
- Sectoral Asset Management
- Janus Capital
- Novartis BioVenture Fund (David Morrissey)
- Atlas Venture (Jean-François Formela)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs